Membranous Nephropathy: Current Understanding in The Light of New Advances

Membranous Nephropathy: Current Understanding in The Light of New Advances

Bibliographic Details
Main Authors:	Hakan Özer, Ismail Baloğlu, Fernando C Fervenza, Kultigin Türkmen
Format:	Article
Language:	English
Published:	AVES 2023-04-01
Series:	Turkish Journal of Nephrology
Online Access:	https://turkjnephrol.org/en/membranous-nephropathy-current-understanding-in-the-light-of-new-advances-137115

Similar Items

Two Different Presentation of C3 Glomerulonephritis Treated with Eculizumab: Two Cases and Brief Overview
by: Yasin Öztürk, et al.
Published: (2023-01-01)

Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?
by: Hakan Ozer, et al.
Published: (2024-03-01)

The Relationship of Epicardial Adipose Tissue and Cardiovascular Disease in Chronic Kidney Disease and Hemodialysis Patients
by: Kultigin Turkmen, et al.
Published: (2022-02-01)

Monocyte-HDL Ratio: Can It Be Included in the Follow-Up of Diabetes Mellitus and Diagnosis of Diabetic Nephropathy?
by: Kader Zeybek Aydoğan, et al.
Published: (2023-08-01)

Proteomic Analysis of Complement Proteins in Membranous Nephropathy
by: Aishwarya Ravindran, et al.
Published: (2020-05-01)

Membrane transport abnormalities in patients with renal failure
by: Fervenza, F, et al.
Published: (1990)

Advances in Membranous Nephropathy
by: Pierre Ronco, et al.
Published: (2021-02-01)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2022-05-01)

The characteristics of patients returning to hemodialysis due to nonfunctioning graft in Turkey
by: Ilkem Altun, et al.
Published: (2019-01-01)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
by: Maciej Tota, et al.
Published: (2023-04-01)

Membranous nephropathy with light chain restriction
by: Catarina Isabel Ribeiro, et al.
Published: (2021-01-01)

Membranous nephropathy: the current state of the problem
by: O.N. Sharapov, et al.
Published: (2023-06-01)

Retrospective Evaluation of Therapeutic Plasma Exchange in Nephrology Clinic: A Single-Center Experience
by: Hatice Ozge Serin, et al.
Published: (2023-04-01)

Idiopathic membranous nephropathy: Evolution in understanding the problem
by: I N Bobkova, et al.
Published: (2016-06-01)

Advances in Pathogenesis of Idiopathic Membranous Nephropathy
by: Zhifeng Xu, et al.
Published: (2020-06-01)

Advances in antigens associated with Idiopathic Membranous Nephropathy
by: Shan-Shan Li, et al.
Published: (2021-11-01)

Research advances of obinutuzumab in the treatment of membranous nephropathy
by: Xiao-jing Lin, et al.
Published: (2024-01-01)

A Rare Case: Improved Heart Failure with Anti-Complement Therapy in Complement-Dependent Hemolytic Uremic Syndrome
by: Hakan Özer, et al.
Published: (2023-01-01)

Treatment of membranous nephropathy: Perspectives on current and future therapies
by: Monarch Shah, et al.
Published: (2023-01-01)

Detection of Phospholipase A2 Receptor Related Membranous Nephropathy in Membranous Nephropathy Patient
by: Alaa Elmaghraby, et al.
Published: (2020-07-01)

Membranous nephropathy
by: Márcio Dantas, et al.
Published: (2023-07-01)

Altered pupillary light responses are associated with the severity of autonomic symptoms in patients with Fabry disease
by: Gulfidan Bitirgen, et al.
Published: (2021-04-01)

Update on New Antigens in the Pathogenesis of Membranous Nephropathy
by: Maurizio Salvadori, et al.
Published: (2022-09-01)

Experimental models for elderly patients with membranous nephropathy: Application and advancements
by: Xinyue Tang, et al.
Published: (2024-01-01)

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
by: Yan-Ni Wang, et al.
Published: (2022-05-01)

Role of light and immunofluorescence microscopy to differentiate primary and secondary membranous nephropathy
by: Keya Basu, et al.
Published: (2022-01-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
by: Yating Du, et al.
Published: (2023-01-01)

An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression
by: Ladan Zand, et al.
Published: (2020-01-01)

The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease
by: Kultigin Turkmen, et al.
Published: (2023-01-01)

Evolution in the understanding of idiopathic membranous nephropathy pathogenesis: from experimental models to the clinic
by: I. N. Bobkova, et al.
Published: (2018-01-01)

Membranous Nephropathy With Crescents
by: Rasha Alawieh, et al.
Published: (2020-04-01)

Membranous nephropathy and malignancy
by: Vinod Khelgi, et al.
Published: (2021-01-01)

Treatment of Membranous Nephropathy
by: Passerini Patrizia, et al.
Published: (2000-01-01)

Therapeutic advances of rituximab alone or plus other drugs for membranous nephropathy
by: Chao Zhang, et al.
Published: (2024-01-01)

New risk score for predicting progression of membranous nephropathy
by: Hu Xiaofan, et al.
Published: (2019-02-01)

Light chain nephropathy
by: Sihem Darouich, et al.
Published: (2015-01-01)

Educational Case: Membranous Nephropathy
by: Christina C. Smith MS, et al.
Published: (2018-12-01)

Recent advances in managing and understanding diabetic nephropathy [version 1; referees: 3 approved]
by: Sydney C.W. Tang, et al.
Published: (2016-05-01)

IgA Nephropathy: Current Treatment and New Insights
by: Dimitra Petrou, et al.
Published: (2023-06-01)